Skip to main content
Table of Contents
Print

Can Cannabis Reduce Depressive Relapse Rates in Mood Disorder Patients? 

Author: Dr. Clarissa Morton, PharmD

The potential of cannabis for relapse prevention is a growing area of interest in psychiatry. For individuals living with mood disorders, one of the greatest challenges is avoiding recurrence after initial recovery. Patients with a mental health condition such as depression often face cycles of remission and relapse, making long-term strategies vital. Cannabis is being explored for its possible role in stabilising mood and supporting maintenance care. 

Although evidence is still limited, cannabinoids like CBD may offer protective effects by regulating stress and emotional reactivity. 

Cannabis And Its Role in Preventing Recurrence 

When considering cannabis for relapse prevention, researchers are looking at how cannabinoids may fit into existing strategies for long-term stability. 

Relapse Prevention of Depression 

Some studies suggest cannabis could contribute to the relapse prevention of depression, particularly through its impact on anxiety and sleep regulation, though findings remain mixed. 

Cannabis And Relapse 

The relationship between cannabis and relapse is complex: while some patients report stability, others experience dependency or withdrawal that may worsen mood outcomes. 

Recurrence of Depression  

The recurrence of depression and cannabis role debate highlight cannabis as a potential adjunct in maintenance therapy, but one requiring careful monitoring and individualised plans. 

In summary, while cannabis for relapse prevention holds promise, its role remains experimental, with benefits varying widely among patients with mood disorders. 

For those considering cannabis as part of long-term care, providers like LeafEase can offer professional guidance tailored to relapse prevention strategies. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Mood Disorders.

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories